# Hidefumi Kinoshita

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hidefumi-kinoshita/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,822 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 30 |
| i10-index | 122 |
| Last Known Institution | Kansai Medical University |
| OpenAlex ID | https://openalex.org/A5082935375 |
| ORCID iD | 0000-0002-6481-1967 |
| Works | 366 |

## Researcher papers

- [Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-alone-or-combined-with-chemotherapy-versus-chemotherapy-as-first/)
- [Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.](https://scholariq.org/papers/methylation-of-the-androgen-receptor-promoter-cpg-island-is-associated-with-loss/)
- [Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.](https://scholariq.org/papers/methylation-of-the-androgen-receptor-minimal-promoter-silences-transcription-in/)
- [Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma](https://scholariq.org/papers/formation-of-8-hydroxy-2-deoxyguanosine-and-4-hydroxy-2-nonenal-modified/)
- [Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient](https://scholariq.org/papers/antiandrogen-bicalutamide-promotes-tumor-growth-in-a-novel-androgen-dependent/)
- [p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.](https://scholariq.org/papers/p16-prb-pathway-alterations-are-required-for-bypassing-senescence-in-human/)
- [Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones](https://scholariq.org/papers/characteristics-and-outcomes-of-ureteroscopic-treatment-in-2650-patients-with/)
- [Ureteral Wall Thickness as a Preoperative Indicator of Impacted Stones in Patients With Ureteral Stones Undergoing Ureteroscopic Lithotripsy](https://scholariq.org/papers/ureteral-wall-thickness-as-a-preoperative-indicator-of-impacted-stones-in/)
- [Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population](https://scholariq.org/papers/androgen-receptor-ki67-and-p53-expression-in-radical-prostatectomy-specimens/)
- [Increased risk of prostate cancer associated with <i>AA</i> genotype of <i>cyclin D1</i> gene <i>A</i>870<i>G</i> polymorphism](https://scholariq.org/papers/increased-risk-of-prostate-cancer-associated-with-i-aa-i-genotype-of-i-cyclin-d1/)
- [Analysis of the tractive force pattern on a knot by force measurement during laparoscopic knot tying](https://scholariq.org/papers/analysis-of-the-tractive-force-pattern-on-a-knot-by-force-measurement-during/)
- [Development and evaluation of vesicourethral anastomosis bench-top model for measurement of traction force on urethra in robotic surgery](https://scholariq.org/papers/development-and-evaluation-of-vesicourethral-anastomosis-bench-top-model-for/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)

## Researcher university

- [Kansai Medical University](https://scholariq.org/institutions/kansai-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.